Why is Symbiox Investme falling/rising?

As of 30-Jun, Symbiox Investment & Trading Co Ltd is experiencing a decline in its stock price, currently at 2.75, which reflects a decrease of 0.02 or 0.72%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 10.71% during this period. Additionally, it is trading below all key moving averages, indicating a bearish trend. Despite a year-over-year return of 1.85%, the company has faced operating losses and a stagnant profit growth rate, which contributes to its weak long-term fundamental strength. The stock is currently valued at a discount compared to its peers, but the overall financial health, including a low return on equity and negative earnings per share, raises concerns among investors.
In the broader market context, the stock's performance over the past week and month has been significantly worse than the benchmark Sensex, with declines of 5.17% and 15.38%, respectively, while the Sensex has shown positive returns of 2.09% and 2.65%. This stark contrast highlights the stock's struggles relative to the market. Although there has been a notable increase in investor participation, as indicated by a 106.85% rise in delivery volume, the overall sentiment remains negative due to the company's operational challenges and lack of growth, leading to a perception of the stock as a strong sell.